Therapeutic Potential of Mesenchymal Stem Cells in Regenerative Medicine
Open Access
- 19 March 2013
- journal article
- review article
- Published by Hindawi Limited in Stem Cells International
- Vol. 2013, 1-15
- https://doi.org/10.1155/2013/496218
Abstract
Mesenchymal stem cells (MSCs) are stromal cells that have the ability to self-renew and also exhibit multilineage differentiation into both mesenchymal and nonmesenchymal lineages. The intrinsic properties of these cells make them an attractive candidate for clinical applications. MSCs are of keen interest because they can be isolated from a small aspirate of bone marrow or adipose tissues and can be easily expandedin vitro. Moreover, their ability to modulate immune responses makes them an even more attractive candidate for regenerative medicine as allogeneic transplant of these cells is feasible without a substantial risk of immune rejection. MSCs secrete various immunomodulatory molecules which provide a regenerative microenvironment for a variety of injured tissues or organ to limit the damage and to increase self-regulated tissue regeneration. Autologous/allogeneic MSCs delivered via the bloodstream augment the titers of MSCs that are drawn to sites of tissue injury and can accelerate the tissue repair process. MSCs are currently being tested for their potential use in cell and gene therapy for a number of human debilitating diseases and genetic disorders. This paper summarizes the current clinical and nonclinical data for the use of MSCs in tissue repair and potential therapeutic role in various diseases.Keywords
This publication has 150 references indexed in Scilit:
- Lysophosphatidic Acid Induces Migration of Human Lung-Resident Mesenchymal Stem Cells Through the β-Catenin PathwayThe International Journal of Cell Cloning, 2012
- Excitation–contraction coupling in ventricular myocytes is enhanced by paracrine signaling from mesenchymal stem cellsJournal of Molecular and Cellular Cardiology, 2012
- Mesenchymal stem cells: a double-edged sword in regulating immune responsesCell Death & Differentiation, 2012
- Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes MellitusThe International Journal of Cell Cloning, 2011
- A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial InfarctionJournal of the American College of Cardiology, 2009
- Endovenous Administration of Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells Prevents Renal Failure in Diabetic MiceTransplantation and Cellular Therapy, 2009
- The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosisLiver Transplantation, 2009
- Human bone marrow‐derived mesenchymal stem cells induce Th2‐polarized immune response and promote endogenous repair in animal models of multiple sclerosisGlia, 2009
- Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltrationNeuroscience Letters, 2008
- Bone regeneration by implantation of purified, culture‐expanded human mesenchymal stem cellsJournal of Orthopaedic Research, 1998